Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients

Assies, 2014, Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity, Acta Psychiatr. Scand., 130, 163, 10.1111/acps.12265 Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc. B, 57, 289 Cantrell, 2001, Phosphoinositide 3-kinase signalling pathways, J. Cell Sci., 114, 1439, 10.1242/jcs.114.8.1439 Celano, 2011, Depression and cardiac disease: a review, Cardiol. Rev., 19, 130, 10.1097/CRD.0b013e31820e8106 Chang, 2015, Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression, Brain Behav. Immun., 44, 28, 10.1016/j.bbi.2014.11.005 Chen, 2008, Regulation of brain polyunsaturated fatty acid uptake and turnover, Prostaglandins Leukot. Essent. Fatty Acids, 79, 85, 10.1016/j.plefa.2008.09.003 Chen, 2011, Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans, Nutr. Metab., 8, 25, 10.1186/1743-7075-8-25 Davidson, 2006, Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report, Psychosom. Med., 68, 645, 10.1097/01.psy.0000233233.48738.22 Demirkan, 2013, Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study, J. Psychiatr. Res., 47, 357, 10.1016/j.jpsychires.2012.11.001 Dowlati, 2010, A meta-analysis of cytokines in major depression, Biol. Psychiatry, 67, 446, 10.1016/j.biopsych.2009.09.033 Frasure-Smith, 2004, Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes, Biol. Psychiatry, 55, 891, 10.1016/j.biopsych.2004.01.021 Grosso, 2014, Role of omega-3 Fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials, PLoS One, 9, e96905, 10.1371/journal.pone.0096905 Gulbins, 2015, A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression, J. Neurochem., 134, 183, 10.1111/jnc.13145 Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Harris, 2010, Biological variability of blood omega-3 biomarkers, Clin. Biochem., 43, 338, 10.1016/j.clinbiochem.2009.08.016 Harris, 2004, The Omega-3 index: a new risk factor for death from coronary heart disease?, Prev. Med., 39, 212, 10.1016/j.ypmed.2004.02.030 Hicks, 2006, Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry, Biochim. Biophys. Acta, 1761, 1022, 10.1016/j.bbalip.2006.05.010 Kidd, 2007, Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids, Altern. Med. Rev., 12, 207 Kita, 2006, Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s, Biochim. Biophys. Acta, 1761, 1317, 10.1016/j.bbalip.2006.08.001 Kornhuber, 2005, High activity of acid sphingomyelinase in major depression, J. Neural. Transm., 112, 1583, 10.1007/s00702-005-0374-5 Lauzon, 2003, Depression and prognosis following hospital admission because of acute myocardial infarction, CMAJ, 168, 547 Leslie, 2014, Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model, Lipids Health Dis., 13, 96, 10.1186/1476-511X-13-96 Lin, 2010, A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression, Biol. Psychiatry, 68, 140, 10.1016/j.biopsych.2010.03.018 Lotrich, 2013, Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6, Brain Behav. Immun., 31, 48, 10.1016/j.bbi.2012.08.007 Mazereeuw, 2015, Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study, Neuropsychiatr. Dis. Treat., 11, 2309 Mazereeuw, 2015, A meta-analysis of lipid peroxidation markers in major depression, Neuropsychiatr. Dis. Treat., 11, 2479 Mielke, 2010, Alterations of the sphingolipid pathway in Alzheimer’s disease: new biomarkers and treatment targets?, Neuromolecular Med., 12, 331, 10.1007/s12017-010-8121-y Molloy, 1999 Pandey, 2013, Signal transduction abnormalities in suicide: focus on phosphoinositide signaling system, CNS Neurol. Disord. Drug Targets, 12, 941, 10.2174/18715273113129990097 Penninx, 2001, Depression and cardiac mortality: results from a community-based longitudinal study, Arch. Gen. Psychiatry, 58, 221, 10.1001/archpsyc.58.3.221 Raphael, 2013, Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis, Int. J. Mol. Sci., 14, 21167, 10.3390/ijms141021167 Riehle, 2013, Role of phosphatidylinositol 3,4,5-trisphosphate in cell signaling, Adv. Exp. Med. Biol., 991, 105, 10.1007/978-94-007-6331-9_7 Schmitz, 2008, The opposing effects of n-3 and n-6 fatty acids, Prog. Lipid Res., 47, 147, 10.1016/j.plipres.2007.12.004 Serhan, 2015, Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome, Biochim. Biophys. Acta, 1851, 397, 10.1016/j.bbalip.2014.08.006 van Meer, 2008, Membrane lipids: where they are and how they behave, Nat. Rev. Mol. Cell Biol., 9, 112, 10.1038/nrm2330 Vollmer-Conna, 2015, Characterising acute coronary syndrome-associated depression: let the data speak, Brain Behav. Immun., 48, 19, 10.1016/j.bbi.2015.03.001 Williams, 1988, A structured interview guide for the Hamilton Depression Rating Scale, Arch. Gen. Psychiatry, 45, 742, 10.1001/archpsyc.1988.01800320058007